Aptamer Sciences Inc
291650
Company Profile
Business description
Aptamer Sciences Inc is a research and development based bio venture company. The company is focused on the Aptamer Technology Platform for the development of therapeutic and diagnostic platforms. It develops and facilitates drug development and other diagnostic products.
Contact
15, Pangyo-ro 228beongil
301, Building 3, Complex 1
Pangyo Seven Venture Valley
Bundang-gu, Gyeonggi-do
Seongnam-si13605
KORT: +82 317860317
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
55
Stocks News & Analysis
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
stocks
Is this still an ASX share to own forever?
Find out how this defensive player has fared after earnings.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,140.50 | 11.00 | 0.12% |
| CAC 40 | 7,674.78 | 24.14 | -0.31% |
| DAX 40 | 23,596.98 | 173.35 | -0.73% |
| Dow JONES (US) | 45,335.21 | 286.08 | -0.63% |
| FTSE 100 | 9,208.21 | 8.66 | -0.09% |
| HKSE | 25,417.98 | 359.47 | 1.43% |
| NASDAQ | 21,638.06 | 69.63 | -0.32% |
| Nikkei 225 | 43,018.75 | 438.48 | 1.03% |
| NZX 50 Index | 13,223.53 | 90.33 | 0.69% |
| S&P 500 | 6,466.08 | 36.00 | -0.55% |
| S&P/ASX 200 | 8,871.20 | 8.60 | 0.10% |
| SSE Composite Index | 3,812.51 | 46.64 | 1.24% |